Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 2175-2181, June 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaken, S.
Right arrow Articles by Blumberg, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaken, S.
Right arrow Articles by Blumberg, P. M.

Characterization of Phorbol Ester Receptors and Their Down-Modulation in GH4C1 Rat Pituitary Cells

Susan Jaken1, Armen H. Tashjian, Jr.2 and Peter M. Blumberg3

Interdisciplinary Programs in Health [S. J.] and Laboratory of Toxicology [A. H. T.], Harvard School of Public Health, and Department of Pharmacology, Harvard Medical School [A. H. T., P. M. B.], Boston, Massachusetts 02115

Phorbol ester binding to intact GH4C1 cells, a continuous strain of rat pituitary cells, was measured using [3H]phorbol 12,13-dibutyrate. The binding was saturable; Scatchard analysis indicated one class of high-affinity binding sites (Kd, 11 nM) with 6.4 pmol [3H]phorbol 12,13-dibutyrate bound per mg cell protein at saturation. The relative binding affinities for other phorbol esters and analogs were similar to those demonstrated for binding to homogenates of chick embryo fibroblasts and mouse skin, as well as for tumor promotion in vivo. A close correlation was shown to exist between the binding affinities of these derivatives and their potencies for inducing biological responses in GH4C1 cells, such as decreases in binding of epidermal growth factor and thyrotropin-releasing hormone. A distinctive new finding is the down modulation of phorbol ester binding sites on GH4C1 cells by both homologous and heterologous ligands. Prolonged exposure to phorbol esters or thyrotropin-releasing hormone produced a loss of available [3H]-phorbol 12,13-dibutyrate binding sites with a maximal decrease to about 20% of control after 24 hr of treatment. Scatchard analysis indicated that the decrease in binding was due to a loss of receptors with no change in affinity. The biological significance of phorbol ester receptor down modulation is not yet known; however, it may represent a mechanism for attenuating cellular responsiveness to phorbol esters in their continued presence.

1 Fellow of the Interdisciplinary Programs in Health, Harvard School of Public Health.

2 Recipient of a research grant from the National Institute of Arthritis, Metabolism, and Digestive Diseases (AM 1101).

3 Recipient of a Research Career Development Award from NIH and a research grant from the National Cancer Institute (CA 22895). To whom requests for reprints should be addressed.

Received 11/24/80. Accepted 2/19/81.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Chen, C. Gould, R. Garza, T. Gao, R. Y. Hampton, and A. C. Newton
Amplitude Control of Protein Kinase C by RINCK, a Novel E3 Ubiquitin Ligase
J. Biol. Chem., November 16, 2007; 282(46): 33776 - 33787.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Inagaki, R. Begley, F. Ikeno, and D. Mochly-Rosen
Cardioprotection by {epsilon}-Protein Kinase C Activation From Ischemia: Continuous Delivery and Antiarrhythmic Effect of an {epsilon}-Protein Kinase C-Activating Peptide
Circulation, January 4, 2005; 111(1): 44 - 50.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.